{
    "Trade/Device Name(s)": [
        "HDL-Cholesterol Gen.4"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K162593",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021316"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS"
    ],
    "Summary Letter Date": "September 14, 2016",
    "Summary Letter Received Date": "September 16, 2016",
    "Submission Date": "September 13, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "HDL-cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Li-heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c systems",
        "cobas c 501 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzymatic colorimetric test",
        "Photometric measurement"
    ],
    "Methodologies": [
        "Enzymatic colorimetric determination"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche HDL-Cholesterol Gen.4 homogeneous enzymatic colorimetric reagent for quantitative determination of HDL-cholesterol in serum and plasma",
    "Indications for Use Summary": "In vitro diagnostic test for the quantitative determination of HDL-cholesterol concentration in human serum and plasma on Roche/Hitachi cobas c systems; used in diagnosis and treatment of lipid disorders, atherosclerosis, and various liver and renal diseases.",
    "fda_folder": "Clinical Chemistry"
}